id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-339854-scb7pz87	Overend, Christopher	The synthetic futures of vesicular stomatitis virus	2012-07-11		.txt	text/plain	1090	54	36	Trends in Biotechnology October 2012, Vol. 30, No. 10 Synthetic viruses: a new opportunity to understand and prevent viral disease Vesicular stomatitis virus: re-inventing the bullet Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4(+) cells are required at the time of challenge for optimal protection Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain SARS vaccine based on a replicationdefective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector Writing DNA with GenoCAD (TM) Vesicular stomatitis virus (VSV) is one of the most promising viruses for engineering vaccines and oncolytic therapies [2] .	cache/cord-339854-scb7pz87.txt	txt/cord-339854-scb7pz87.txt
